New Two-Pronged attack tested against aggressive lung cancer
Disease control
Recruiting now
This study is testing whether a new two-part treatment can better control an aggressive form of lung cancer and keep it from getting worse. Previously untreated patients will first receive standard chemotherapy plus an immunotherapy drug, then continue with a maintenance therapy …
Phase: PHASE2 • Sponsor: Muhammad Furqan • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC